Literature DB >> 25838281

Bridging to transplant with azacitidine in juvenile myelomonocytic leukemia: a retrospective analysis of the EWOG-MDS study group.

Annamaria Cseh1, Charlotte M Niemeyer2, Ayami Yoshimi1, Michael Dworzak3, Henrik Hasle4, Marry M van den Heuvel-Eibrink5, Franco Locatelli6, Riccardo Masetti7, Markus Schmugge8, Ute Groß-Wieltsch9, Andrea Candás10, Andreas E Kulozik11, Lale Olcay12, Meinolf Suttorp13, Ingrid Furlan14, Brigitte Strahm1, Christian Flotho2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25838281     DOI： 10.1182/blood-2015-01-619734

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  17 in total

1.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

Review 2.  Treatment advances for pediatric and adult onset neoplasms with monocytosis.

Authors:  Kristen B McCullough; Alexis K Kuhn; Mrinal M Patnaik
Journal:  Curr Hematol Malig Rep       Date:  2021-03-16       Impact factor: 3.952

Review 3.  JMML genomics and decisions.

Authors:  Charlotte M Niemeyer
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

4.  Juvenile myelomonocytic leukemia presenting in an infant with a subdural hematoma.

Authors:  William A Lambert; Joseph A DiGiuseppe; Tatiana Lara-Ospina; Markus J Bookland; Jonathan E Martin; David S Hersh
Journal:  Childs Nerv Syst       Date:  2021-01-06       Impact factor: 1.475

Review 5.  Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia.

Authors:  Christian Flotho
Journal:  Epigenetics       Date:  2019-03-08       Impact factor: 4.528

6.  Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.

Authors:  Christopher C Dvorak; Prakash Satwani; Elliot Stieglitz; Mitchell S Cairo; Ha Dang; Qinglin Pei; Yun Gao; Donna Wall; Tali Mazor; Adam B Olshen; Joel S Parker; Samir Kahwash; Betsy Hirsch; Susana Raimondi; Neil Patel; Micah Skeens; Todd Cooper; Parinda A Mehta; Stephan A Grupp; Mignon L Loh
Journal:  Pediatr Blood Cancer       Date:  2018-03-12       Impact factor: 3.167

7.  Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia.

Authors:  Anna Hecht; Julia Meyer; Farid F Chehab; Kristie L White; Kevin Magruder; Christopher C Dvorak; Mignon L Loh; Elliot Stieglitz
Journal:  Pediatr Blood Cancer       Date:  2019-07-26       Impact factor: 3.167

Review 8.  Pediatric Neoplasms Presenting with Monocytosis.

Authors:  Jacob R Greenmyer; Mira Kohorst
Journal:  Curr Hematol Malig Rep       Date:  2021-02-25       Impact factor: 3.952

9.  Sustained remission with azacitidine monotherapy and an aberrant precursor B-lymphoblast population in juvenile myelomonocytic leukemia.

Authors:  Saman K Hashmi; Jyotinder N Punia; Andrea N Marcogliese; Amos S Gaikwad; Kevin E Fisher; Angshumoy Roy; Pulivarthi Rao; Dolores H Lopez-Terrada; Jo Ringrose; Mignon L Loh; Charlotte M Niemeyer; Rachel E Rau
Journal:  Pediatr Blood Cancer       Date:  2019-06-28       Impact factor: 3.167

10.  Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2-/-γc-/- mice.

Authors:  Christopher Felix Krombholz; Konrad Aumann; Matthias Kollek; Daniela Bertele; Silvia Fluhr; Mirjam Kunze; Charlotte M Niemeyer; Christian Flotho; Miriam Erlacher
Journal:  Haematologica       Date:  2016-02-17       Impact factor: 9.941
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.